Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average.
Left:
||||
Free cash flow yield
Latest
-97.32%
↓ 246% below average
Average (5y)
-28.14%
Historical baseline
Range
High:0.56%
Low:-97.32%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -97.32% | -184.8% |
| 2023 | -34.17% | -51.1% |
| 2022 | -22.61% | -121.5% |
| 2021 | -10.21% | -100.2% |
| 2020 | -5.10% | -1006.5% |
| 2019 | 0.56% | - |